Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults
Glenda E. Gray, Linda-Gail Bekker, Fatima Laher et al. · New England Journal of Medicine · 2021 · Randomised trial
Abstract only
Virology
Filters2 filters applied
Year
Readable here
Study type
Licence
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial
Kenneth H. Mayer, Kelly E. Seaton, Yunda Huang et al. · PLOS Medicine · 2017 · Randomised trial
Full textCC0
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
Jacob Hurst, Matthias Hoffmann, Matthew Pace et al. · Nature Communications · 2015 · Randomised trial
Full textCC BY